Invitrogen To Present at the UBS Global Life Sciences Conference

CARLSBAD, Calif.--(BUSINESS WIRE)--Sept. 22, 2004--Invitrogen Corporation (Nasdaq:IVGN) announced that Gregory T. Lucier, Chairman and Chief Executive Officer, will be speaking at the UBS Global Life Sciences Conference on Monday, September 27, 2004 at 8:30 a.m. (ET). The conference is being held at The Grand Hyatt in New York, N.Y.

Mr. Lucier's presentation will be webcast live at www.ibb.ubs.com. It will be available for viewing following the conference from the Investor Relations section of Invitrogen's website, www.invitrogen.com.

About Invitrogen

Invitrogen Corporation (Nasdaq:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bio-production. Invitrogen's own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, bioinformatics and cell biology -- placing Invitrogen's products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, Calif. and conducts business in more than 70 countries around the world. The company globally employs approximately 4,000 scientists and other professionals. For more information about Invitrogen visit the company's web site at www.invitrogen.com.